Results 1 to 10 of about 76,985,047 (293)

Improving thymus implantation for congenital athymia with interleukin‐7 [PDF]

open access: yesClinical & Translational Immunology, 2023
Objectives Thymus implantation is a recently FDA‐approved therapy for congenital athymia. Patients receiving thymus implantation develop a functional but incomplete T cell compartment.
Hyunjung Min   +6 more
doaj   +2 more sources

Interleukin-7 enhances in vitro development and blastocyst quality in porcine parthenogenetic embryos [PDF]

open access: yesFrontiers in Veterinary Science, 2022
Interleukin-7 (IL-7), a vital factor that affects cell development, proliferation, and survival, plays an important role in oocyte maturation. However, its role in embryonic development remains unknown.
Dongjin Oh   +21 more
doaj   +2 more sources

The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers [PDF]

open access: yesJournal of Immunotherapy and Precision Oncology, 2022
Immunotherapies for the treatment of solid tumors continue to develop in preclinical and clinical research settings. Unfortunately, for many patients the tumor fails to respond or becomes resistant to therapies such as checkpoint inhibitors (CPIs ...
Michael Brandon Ware   +6 more
doaj   +2 more sources

Potential of interleukin-7 in sepsis as a biomarker and therapeutic agent: a narrative review [PDF]

open access: yesFrontiers in Medicine
ObjectiveThis study seeks to examine the dynamics of endogenous interleukin-7 (IL-7) and its associated regulatory factors in sepsis, and to elucidate the mechanisms by which exogenous IL-7 may confer therapeutic benefits.
Tong Zhang   +5 more
doaj   +2 more sources

Deregulation of the Interleukin-7 Signaling Pathway in Lymphoid Malignancies [PDF]

open access: yesPharmaceuticals, 2021
The cytokine interleukin-7 (IL-7) and its receptor are critical for lymphoid cell development. The loss of IL-7 signaling causes severe combined immunodeficiency, whereas gain-of-function alterations in the pathway contribute to malignant transformation ...
Inge Lodewijckx, Jan Cools
doaj   +2 more sources

Analysis of interleukin 7 and platelet-derived growth factor BB mRNA expression as potential markers in erythema nodosum leprosum [PDF]

open access: yesDermatology Reports, 2023
Introduction: Erythema Nodosum Leprosum (ENL) is an immunological complication of leprosy characterized by acute inflammation of the skin, nerves, and other organs. Identifying laboratory parameters are important to early diagnosis of leprosy reactions.
Fitri Kadarsih Banjar   +9 more
doaj   +2 more sources

Targeting Interleukin-7 Signalling in Ulcerative Colitis: Rationale and Emerging Clinical Evidence [PDF]

open access: yesLife
Ulcerative colitis (UC) remains difficult to control in a substantial proportion of patients despite an expanding range of advanced therapies. Interleukin-7 (IL-7) is a homeostatic cytokine that supports lymphocyte survival, persistence and intestinal ...
Magdalini Manti   +3 more
doaj   +2 more sources

Interleukin-7 induces EMT to promote tumor growth and metastasis in NSCLC via Notch1/TGF-β pathway [PDF]

open access: yesScientific Reports
Interleukin 7 (IL‑7) regulates lymphangiogenesis and proliferation, inhibits apoptosis and autophagy in non‑small cell lung cancer (NSCLC). However, the role and detailed molecular mechanism of IL‑7 involved in NSCLC epithelial-to-mesenchymal transition (
Yajiao Shao   +7 more
doaj   +2 more sources

Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2021
Objectives: Interleukin-7 (IL-7) secures B cell maturation, regulatory T and natural killer (NK) cell survival, and homeostasis, all of which are important for beneficial immunomodulation in pulmonary arterial hypertension (PAH).
Franziska Diekmann   +6 more
doaj   +2 more sources

Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial [PDF]

open access: yesAnnals of Intensive Care, 2023
Background Profound lymphopenia is an independent predictor of adverse clinical outcomes in sepsis. Interleukin-7 (IL-7) is essential for lymphocyte proliferation and survival.
Thomas Daix   +14 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy